KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $213,333 | +44.1% | 22,153 | +34.7% | 0.00% | – |
| Q2 2023 | $148,014 | -95.8% | 16,446 | -96.8% | 0.00% | -100.0% |
| Q4 2022 | $3,529,233 | -53.5% | 522,076 | -0.1% | 0.00% | -57.1% |
| Q3 2022 | $7,584,000 | +48.3% | 522,705 | +0.6% | 0.01% | +75.0% |
| Q2 2022 | $5,114,000 | -28.3% | 519,709 | +7.4% | 0.00% | -20.0% |
| Q1 2022 | $7,136,000 | +42.2% | 484,103 | +27.7% | 0.01% | +66.7% |
| Q4 2021 | $5,017,000 | +4.6% | 379,233 | +38.0% | 0.00% | 0.0% |
| Q3 2021 | $4,796,000 | -27.1% | 274,853 | +0.0% | 0.00% | -25.0% |
| Q2 2021 | $6,583,000 | +17.4% | 274,768 | +25.9% | 0.00% | 0.0% |
| Q1 2021 | $5,605,000 | – | 218,163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |